Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)

Name: Dasatinib as Therapy for Myeloproliferative Disorders (MPDs)
Published: 2005
License: Public Domain

M.D. Anderson Cancer Center · 2005

ClinicalTrials.gov · Datasets · License: Public Domain · 2005

Open Source ↗

acute-myeloid-leukemia chronic leukemia targeted-therapy

acute myeloid leukemia, myelodysplastic syndromes, agnogenic myeloid metaplasia, myelofibrosis, hypereosinophilic syndrome, polycythemia vera, mastocytosis, leukemia, myelomonocytic, chronic, targeted therapy, leukemia, acute myeloid leukemia (aml), myelodysplastic syndrome (mds)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 841115
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.